Pancreatic cancer: In gemcitabine-resistant pancreatic cancer cells, Wang et al. [52] observed increased PAK1 expression and found that PAK1 activation induces resistance through modulating the Wnt/β-catenin signaling cascade. Here, PAK1 is linked to pancreatic neoplasm.